SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GENSET - GENXY
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (150)2/22/2001 2:15:00 PM
From: nigel bates  Read Replies (1) of 200
 
From Genomeweb... thanks, Nathan -

"...Feb 21 - Faced with growing concern from investors about prospects for future profitability, a number of genomics tool makers, large and small, have recently announced plans to refashion themselves as drug developers.
But Nathan Myhrvold, the revered software visionary turned biotechnology venture capitalist, on Wednesday warned genomics software and tool companies against rushing into the field of drug discovery.
"I think it's just ridiculously wrong. I think that's a terribly short-sighted thing," Myhrvold told attendees at the Biotechnology Industry Organization's CEO and Investor Conference in New York..."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News